Shandong Shanda Wit Science and Technology Co Ltd
Shandong Wit Dyne Health Co.,Ltd. engages in the pharmaceutical business in China. Its medical products include azithromycin granules, licorice zinc granules, compound calcium carbonate, vitamin AD drops, epalrestat tablets, valsartan hydrochlorothiazide gel, roxithromycin, rosiglitazone tartrate tablets, and glimepiride tablets. The company also provides dextran iron granules, oral rehydration s… Read more
Market Cap & Net Worth: Shandong Shanda Wit Science and Technology Co Ltd (000915)
Shandong Shanda Wit Science and Technology Co Ltd (SHE:000915) has a market capitalization of $1.08 Billion (CN¥7.89 Billion) as of March 18, 2026. Listed on the SHE stock exchange, this China-based company holds position #8685 globally and #1677 in its home market, demonstrating a 4.50% increase in market value over the past year.
Market capitalization, also known as net worth in stock markets, is calculated by multiplying Shandong Shanda Wit Science and Technology Co Ltd's stock price CN¥33.69 by its total outstanding shares 234331485 (234.33 Million).
Shandong Shanda Wit Science and Technology Co Ltd Market Cap History: 2015 to 2026
Shandong Shanda Wit Science and Technology Co Ltd's market capitalization history from 2015 to 2026. Data shows growth from $722.82 Million to $1.08 Billion (2.73% CAGR).
Shandong Shanda Wit Science and Technology Co Ltd Market Cap to Earnings & Revenue Ratios Timeline
This chart shows how Shandong Shanda Wit Science and Technology Co Ltd's valuation ratios have evolved. The Price to Sales (P/S) ratio compares market cap to revenue, while the Price to Earnings (P/E) ratio compares market cap to net income. Lower values may indicate a more undervalued company relative to its financial performance.
Latest Price to Sales (P/S) Ratio
0.42x
Shandong Shanda Wit Science and Technology Co Ltd's market cap is 0.42 times its annual revenue
1.02x
Lower than industry averageLatest Price to Earnings (P/E) Ratio
1.75x
Shandong Shanda Wit Science and Technology Co Ltd's market cap is 1.75 times its annual earnings
10.35x
Lower than industry averageWhat These Ratios Tell Investors:
- Price to Sales (P/S) Ratio: Shows how much investors are paying for each dollar of the company's sales. Lower P/S ratios may indicate undervaluation.
- Price to Earnings (P/E) Ratio: Shows how much investors are paying for each dollar of the company's earnings. This is one of the most common valuation metrics.
- Trends in these ratios over time can indicate changing investor sentiment about the company's future growth prospects.
- Industry comparison provides context for whether the company is valued higher or lower than peers.
| Year | Market Cap (USD) | Revenue (USD) | Net Income (USD) | P/S Ratio | P/E Ratio |
|---|---|---|---|---|---|
| 2015 | $722.82 Million | $1.23 Billion | $152.46 Million | 0.59x | 4.74x |
| 2016 | $868.52 Million | $1.54 Billion | $198.39 Million | 0.56x | 4.38x |
| 2017 | $810.25 Million | $1.77 Billion | $243.20 Million | 0.46x | 3.33x |
| 2018 | $403.29 Million | $1.53 Billion | $129.69 Million | 0.26x | 3.11x |
| 2019 | $733.14 Million | $1.80 Billion | $204.10 Million | 0.41x | 3.59x |
| 2020 | $653.03 Million | $1.82 Billion | $290.76 Million | 0.36x | 2.25x |
| 2021 | $860.49 Million | $2.03 Billion | $380.26 Million | 0.42x | 2.26x |
| 2022 | $1.32 Billion | $2.34 Billion | $526.86 Million | 0.56x | 2.50x |
| 2023 | $857.92 Million | $2.48 Billion | $585.26 Million | 0.35x | 1.47x |
| 2024 | $899.99 Million | $2.13 Billion | $515.59 Million | 0.42x | 1.75x |
Competitor Companies of 000915 by Market Capitalization
Companies near Shandong Shanda Wit Science and Technology Co Ltd in the global market cap rankings as of March 18, 2026.
Key companies related to Shandong Shanda Wit Science and Technology Co Ltd by market ranking:
- Zoetis Inc (NYSE:ZTS): Ranked #410 globally with a market cap of $53.52 Billion USD.
- Haleon plc (NYSE:HLN): Ranked #434 globally with a market cap of $49.87 Billion USD.
- Takeda Pharmaceutical Co. Ltd. (PINK:TKPHF): Ranked #457 globally with a market cap of $47.47 Billion USD.
- Jiangsu Hengrui Medicine Co Ltd (SHG:600276): Ranked #721 globally with a market cap of $28.19 Billion USD ( CN¥206.84 Billion CNY).
| Rank | Company | Symbol | Market Cap | Price |
|---|---|---|---|---|
| #410 | Zoetis Inc | NYSE:ZTS | $53.52 Billion | $121.68 |
| #434 | Haleon plc | NYSE:HLN | $49.87 Billion | $10.60 |
| #457 | Takeda Pharmaceutical Co. Ltd. | PINK:TKPHF | $47.47 Billion | $30.07 |
| #721 | Jiangsu Hengrui Medicine Co Ltd | SHG:600276 | $28.19 Billion | CN¥55.11 |
Shandong Shanda Wit Science and Technology Co Ltd Historical Marketcap From 2015 to 2026
Between 2015 and today, Shandong Shanda Wit Science and Technology Co Ltd's market cap moved from $722.82 Million to $ 1.08 Billion, with a yearly change of 2.73%.
| Year | Market Cap | Change (%) |
|---|---|---|
| 2026 | CN¥1.08 Billion | +1.97% |
| 2025 | CN¥1.06 Billion | +17.25% |
| 2024 | CN¥899.99 Million | +4.90% |
| 2023 | CN¥857.92 Million | -34.96% |
| 2022 | CN¥1.32 Billion | +53.29% |
| 2021 | CN¥860.49 Million | +31.77% |
| 2020 | CN¥653.03 Million | -10.93% |
| 2019 | CN¥733.14 Million | +81.79% |
| 2018 | CN¥403.29 Million | -50.23% |
| 2017 | CN¥810.25 Million | -6.71% |
| 2016 | CN¥868.52 Million | +20.16% |
| 2015 | CN¥722.82 Million | -- |
End of Day Market Cap According to Different Sources
On Mar 18th, 2026 the market cap of Shandong Shanda Wit Science and Technology Co Ltd was reported to be:
| Source | Market Cap |
|---|---|
| Yahoo Finance | $1.08 Billion USD |
| MoneyControl | $1.08 Billion USD |
| MarketWatch | $1.08 Billion USD |
| marketcap.company | $1.08 Billion USD |
| Reuters | $1.08 Billion USD |
Market cap values may vary slightly between sources due to differences in calculation methods, timing, and data refresh rates.